Mepolizumab is the first and only monthly biologic in China tested for COPD patients with blood eosinophil counts (BEC) as low as 150 cells/µL
Cidara will become a wholly owned subsidiary of Merck and the common stock of Cidara will no longer be listed or traded on the Nasdaq Global Market
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027
The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
The Phase II study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of 9MW3811 in patients with pathological scarring
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
Motiva, SmoothSilk, Round and Ergonomix implants represent the latest in plastic surgery innovation
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
The accelerated review covers WCK 5222 for multiple critical infections
Subscribe To Our Newsletter & Stay Updated
